These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 1399133)
21. Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Wabinga HR; Parkin DM; Wabwire-Mangen F; Mugerwa JW Int J Cancer; 1993 Apr; 54(1):26-36. PubMed ID: 8478145 [TBL] [Abstract][Full Text] [Related]
22. The epidemiology of osteosarcoma. Ottaviani G; Jaffe N Cancer Treat Res; 2009; 152():3-13. PubMed ID: 20213383 [TBL] [Abstract][Full Text] [Related]
23. Childhood cancer incidence in the south-east of France. A report of the Provence-Alpes-Côte d'Azur and Corsica Regions Pediatric Cancer Registry, 1984-1991. Bernard JL; Bernard-Couteret E; Coste D; Thyss A; Scheiner C; Perrimond H; Mariani R; Deville A; Michel G; Gentet JC Eur J Cancer; 1993; 29A(16):2284-91. PubMed ID: 8110500 [TBL] [Abstract][Full Text] [Related]
24. Geographic and ethnic variations in the incidence of childhood cancer. Stiller CA; Parkin DM Br Med Bull; 1996 Oct; 52(4):682-703. PubMed ID: 9039726 [TBL] [Abstract][Full Text] [Related]
25. Persisting inequalities in survival patterns of childhood neuroblastoma in Southern and Eastern Europe and the effect of socio-economic development compared with those of the US. Panagopoulou P; Georgakis MK; Baka M; Moschovi M; Papadakis V; Polychronopoulou S; Kourti M; Hatzipantelis E; Stiakaki E; Dana H; Tragiannidis A; Bouka E; Antunes L; Bastos J; Coza D; Demetriou A; Agius D; Eser S; Gheorghiu R; Šekerija M; Trojanowski M; Žagar T; Zborovskaya A; Ryzhov A; Dessypris N; Morgenstern D; Petridou ET Eur J Cancer; 2018 Jun; 96():44-53. PubMed ID: 29673989 [TBL] [Abstract][Full Text] [Related]
26. Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan. Yamamoto K; Hayashi Y; Hanada R; Kikuchi A; Ichikawa M; Tanimura M; Yoshioka S J Clin Oncol; 1995 Aug; 13(8):2033-8. PubMed ID: 7636545 [TBL] [Abstract][Full Text] [Related]
27. Neuroblastoma in Europe: differences in the pattern of disease in the UK. SENSE. Study group for the Evaluation of Neuroblastoma Screening in Europe. Powell JE; Estève J; Mann JR; Parker L; Frappaz D; Michaelis J; Kerbl R; Mutz ID; Stiller CA Lancet; 1998 Aug; 352(9129):682-7. PubMed ID: 9728983 [TBL] [Abstract][Full Text] [Related]
28. Neuroblastoma: epidemiology and pattern of regression. Problems in interpreting results of mass screening. Carlsen NL Am J Pediatr Hematol Oncol; 1992 May; 14(2):103-10. PubMed ID: 1530115 [TBL] [Abstract][Full Text] [Related]
29. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study. Hiyama E; Iehara T; Sugimoto T; Fukuzawa M; Hayashi Y; Sasaki F; Sugiyama M; Kondo S; Yoneda A; Yamaoka H; Tajiri T; Akazawa K; Ohtaki M Lancet; 2008 Apr; 371(9619):1173-80. PubMed ID: 18395578 [TBL] [Abstract][Full Text] [Related]
31. Screening for neuroblastoma: a review of the evidence. Chamberlain J J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511 [TBL] [Abstract][Full Text] [Related]
32. International patterns of cancer incidence in adolescents. Stiller CA Cancer Treat Rev; 2007 Nov; 33(7):631-45. PubMed ID: 17329031 [TBL] [Abstract][Full Text] [Related]
33. Socioeconomic status and the incidence of non-central nervous system childhood embryonic tumours in Brazil. de Camargo B; de Oliveira Ferreira JM; de Souza Reis R; Ferman S; de Oliveira Santos M; Pombo-de-Oliveira MS BMC Cancer; 2011 May; 11():160. PubMed ID: 21545722 [TBL] [Abstract][Full Text] [Related]
34. Effects of mass screening for neuroblastoma on incidence, mortality, and survival rates in Osaka, Japan. Ajiki W; Tsukuma H; Oshima A; Kawa K Cancer Causes Control; 1998 Dec; 9(6):631-6. PubMed ID: 10189049 [TBL] [Abstract][Full Text] [Related]
35. Trends in neuroblastoma in Great Britain: incidence and mortality, 1971-1990. Stiller CA Eur J Cancer; 1993; 29A(7):1008-12. PubMed ID: 8499132 [TBL] [Abstract][Full Text] [Related]
36. International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0-19 years. Linet MS; Brown LM; Mbulaiteye SM; Check D; Ostroumova E; Landgren A; Devesa SS Int J Cancer; 2016 Apr; 138(8):1862-74. PubMed ID: 26562742 [TBL] [Abstract][Full Text] [Related]
37. Effects of mass screening on age-specific incidence of neuroblastoma. Bessho F Int J Cancer; 1996 Aug; 67(4):520-2. PubMed ID: 8759611 [TBL] [Abstract][Full Text] [Related]
38. Incidence and costs of 1987-1994 childhood injuries: demographic breakdowns. Danseco ER; Miller TR; Spicer RS Pediatrics; 2000 Feb; 105(2):E27. PubMed ID: 10654987 [TBL] [Abstract][Full Text] [Related]
39. Poverty and childhood cancer incidence in the United States. Pan IJ; Daniels JL; Zhu K Cancer Causes Control; 2010 Jul; 21(7):1139-45. PubMed ID: 20198506 [TBL] [Abstract][Full Text] [Related]
40. International variations in the incidence of childhood carcinomas. Stiller CA Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):305-10. PubMed ID: 8061578 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]